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CENTRAL VENOUS CATHETERS
Impregnated central venous catheters should be readily
used to reduce risk of bloodstream infection
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consultant intensivist 2, Carrol Gamble professor of medical statistics 3
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Smith and Nolan’s overview of central venous catheters (CVCs)
states that evidence from 56 trials shows that antiseptic or
antimicrobial impregnation of CVCs reduces the risk of
bloodstream infection related to their use.1 2 The dilemma for
clinicians, however, is which types of impregnation work best
and for whom.
The best available evidence on the type of impregnation comes
from a network meta-analysis combining direct and indirect
comparisons.3Rifampicin-minocycline impregnated and heparin
bonded catheters were most effective in reducing related
bloodstream infection.
The question “effective for whom?” firstly needs to be turned
on its head. Are there patients in whom impregnation of CVCs
would act through such different physiological mechanisms that
existing trial results do not apply? We argued this for young
children when we undertook the CATCH trial (www.catchtrial.
org.uk), a three arm trial of heparin bonded or
rifampicin-minocycline CVCs versus standard CVCs in children
in paediatric intensive care, because small lumens are associated
with high rates of thrombosis, potentially over-riding
antimicrobial impregnation.
Secondly, if results apply, do the absolute benefits outweigh
the extra cost of impregnation? New guidelines recommend
impregnated CVCs only in high risk patients or when effective
programmes to reduce CVC infection do not exist. Yet a UK
cost effectiveness study calculated that impregnated CVCs are
cost effective even at bloodstream infection rates as low as 0.2%,
lower than rates seen in many intensive care units.4
Given this abundance of evidence, the puzzle is why the uptake
of impregnated CVCs is limited and their use not supported in
guidelines.What further evidence is needed?More head to head
trials would give direct evidence on type of impregnation on
bloodstream infection.We should be sceptical about the limited
evidence for a lack of effect of impregnation on sepsis and all
cause mortality because of low power and intensive treatment
responses that will bias towards a null effect. And no more trials
on catheter colonisation, a biased and clinically irrelevant
outcome.5
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